Cargando…
In vitro investigations on the toxicity and cell death induced by tamoxifen on two non-breast cancer cell types
Tamoxifen, a potent anticancer agent known to interrupt the enhanced estrogen activity of malignant mammary gland cells, was recently approved by the Food and Drug Administration (FDA) for the treatment of breast cancer. In this investigation, the toxic effects of tamoxifen were evaluated through ce...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi Publishing Corporation
2001
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC129061/ https://www.ncbi.nlm.nih.gov/pubmed/12488602 http://dx.doi.org/10.1155/S1110724301000316 |